A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy

Clinical trial NCT07777861 · RECRUITING

Trial details

NCT number: NCT07777861
Sponsor: Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma Optic Nerve Injury

Start date: 2026-03-18
Primary completion: 2027-10-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.